In clinical trials, Trulicity has been shown to help people with type 2 diabetes lose weight and improve their glycemic control
48 Patients with HFpEF and obesity are usually younger than HFpEF patients without obesity
However, the well-recognized pleotropic effects of GLP-1R agonists (normalization of neurogenesis and synaptic plasticity, protection against neuronal apoptosis, and suppression of increased oxidative stress), in conjunction with the presence of GLP-1Rs in the hypothalamic nuclei that regulate sleep and wakefulness, suggest several possible direct effects of GLP-1R agonists in affecting sleepiness and other related parameters (memory, anxiety, and depression) [77, 114]
bowel movement frequency 14 units weekly
doi:10.1016/S2213-8587(22)00243-1 9
Disclosed herein is use of the formulations disclosed herein for the treatment or prevention of obesity